David Jacob Erle MD
Critical Care Medicine, Pleural Disease
Professor, Medicine, UCSF School of Medicine
Join to View Full Profile
1001 Potrero AveRm 3k1San Francisco, CA 94110
Phone+1 415-206-8314
Fax+1 415-695-1551
Are you Dr. Erle?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. David Erle, MD is a pulmonologist in San Francisco, California. He is currently licensed to practice medicine in California. He is a Professor at UCSF School of Medicine.
Education & Training
University of California (San Francisco)Fellowship, Pulmonary Disease and Critical Care Medicine, 1993 - 1996- University of California (San Francisco)Residency, Internal Medicine, 1984 - 1986
- University of California San Francisco School of MedicineClass of 1984
Certifications & Licensure
CA State Medical License 1985 - 2025
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 2 citationsChronic Viral Reactivation and Associated Host Immune Response and Clinical Outcomes in Acute COVID-19 and Post-Acute Sequelae of COVID-19.Cole Maguire, Jing Chen, Nadine Rouphael, Harry Pickering, Hoang Van Phan
Biorxiv. 2024-11-16 - Microbial dynamics and pulmonary immune responses in COVID-19 secondary bacterial pneumonia.Natasha Spottiswoode, Alexandra Tsitsiklis, Victoria T Chu, Hoang Van Phan, Catherine DeVoe
Nature Communications. 2024-10-29 - Immediate myeloid depot for SARS-CoV-2 in the human lung.Mélia Magnen, Ran You, Arjun A Rao, Ryan T Davis, Lauren Rodriguez
Science Advances. 2024-08-02
Press Mentions
Special Notice Concerning COVID-19February 17th, 2021
‘ImmunoX’ Initiative a Radical Collaboration Across UCSFSeptember 14th, 2018- UCSF Launches Process to Reimagine Parnassus Heights CampusMarch 19th, 2018
Grant Support
- Immune-driven Airway Epithelial Dysfunction in Muco-obstructive AsthmaUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2008–2028
- Immune-driven Airway Epithelial Dysfunction in Muco-obstructive AsthmaUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2008–2028
- Immune-driven Airway Epithelial Dysfunction in Muco-obstructive AsthmaUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2008–2028
- Immune-driven Airway Epithelial Dysfunction in Muco-obstructive AsthmaUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2008–2028
- Immune-driven Airway Epithelial Dysfunction in Muco-obstructive AsthmaUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2008–2028
- Immune-driven Airway Epithelial Dysfunction in Muco-obstructive AsthmaUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2008–2028
- Immune-driven Airway Epithelial Dysfunction in Muco-obstructive AsthmaUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2008–2028
- Multidisciplinary Training Program in Lung DiseaseUNIVERSITY OF CALIFORNIA, SAN FRANCISCO1976–2027
- Multidisciplinary Training Program in Lung DiseaseUNIVERSITY OF CALIFORNIA, SAN FRANCISCO1976–2027
- Multidisciplinary Training Program in Lung DiseaseUNIVERSITY OF CALIFORNIA, SAN FRANCISCO1976–2027
- Airway epithelial cell gene regulation: new mechanisms and therapeutic strategiesUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2019–2026
